GPHN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.803400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.032400E-01
Normal-vs-Stage2
6.385000E-01
Normal-vs-Stage3
4.445400E-01
Normal-vs-Stage4
2.225000E-01
Stage1-vs-Stage2
1.865360E-01
Stage1-vs-Stage3
1.115800E-01
Stage1-vs-Stage4
9.983200E-01
Stage2-vs-Stage3
2.245400E-01
Stage2-vs-Stage4
2.714800E-01
Stage3-vs-Stage4
7.215800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.608600E-01
Normal-vs-AfricanAmerican
4.876600E-01
Normal-vs-Asian
7.959200E-01
Caucasian-vs-AfricanAmerican
4.380800E-01
Caucasian-vs-Asian
1.515010E-01
AfricanAmerican-vs-Asian
2.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.757600E-01
Normal-vs-Female
5.927600E-01
Male-vs-Female
9.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.539000E-01
Normal-vs-Age(41-60Yrs)
4.606600E-01
Normal-vs-Age(61-80Yrs)
6.855200E-01
Normal-vs-Age(81-100Yrs)
4.949400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.503400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.647600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.929200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.926980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.503800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.644400E-01
Normal-vs-Daily Drinker
7.414400E-01
Normal-vs-Weekly Drinker
7.596600E-01
Normal-vs-Occasional Drinker
3.621400E-01
Normal-vs-Social Drinker
5.928200E-01
Non Drinker-vs-Daily Drinker
8.857600E-01
Non Drinker-vs-Weekly Drinker
8.413600E-01
Non Drinker-vs-Occasional Drinker
1.425840E-01
Non Drinker-vs-Social Drinker
5.172000E-01
Daily Drinker-vs-Weekly Drinker
9.414000E-01
Daily Drinker-vs-Occasional Drinker
2.378400E-01
Daily Drinker-vs-Social Drinker
6.436400E-01
Weekly Drinker-vs-Occasional Drinker
3.721800E-01
Weekly Drinker-vs-Social Drinker
7.550000E-01
Occasional Drinker-vs-Social Drinker
5.500400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.999400E-01
Normal-vs-Grade 2
3.200000E-01
Normal-vs-Grade 3
1.890360E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.102570E-01
Grade 1-vs-Grade 3
3.639000E-01
Grade 1-vs-Grade 4
2.999400E-01
Grade 2-vs-Grade 3
2.424400E-01
Grade 2-vs-Grade 4
3.200000E-01
Grade 3-vs-Grade 4
1.890360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.546600E-01
Normal-vs-NonDiabetic
6.335600E-01
Diabetic-vs-NonDiabetic
8.786800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.680200E-01
Normal-vs-NoPancreatitis
5.872600E-01
Pancreatitis-vs-NoPancreatitis
5.364500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.225800E-01
Normal-vs-N1
6.362800E-01
N0-vs-N1
3.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.510400E-01
Normal-vs-TP53-NonMutant
3.541400E-01
TP53-Mutant-vs-TP53-NonMutant
3.853400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
